SYRE vs TXN · $7.60B cap vs P/E 52, rev $10.29B
Spyre Therapeutics Inc. (SYRE) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
SYRE currently screens at market cap $7.60B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the SYRE and TXN stock pages for the full models.
Not investment advice.